Role of cachexia in advanced non-small cell lung cancer patients treated with EGFR-TKIS

Abstract Introduction Cachexia is a multifactorial syndrome associated with impaired physiologic reserve and adverse outcomes in advanced NSCLC. Its relationship with early toxicity and survival during EGFR-tyrosine kinase inhibitor (EGFR-TKI) therapy remains insufficiently characterized. We evaluat...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Jenny G. Turcott, Cittim B. Palomares-Palomares, Eduardo Rios-Garcia, Daniela Cardenas-Fernandez, Diego A. Diaz-Garcia, Salvador Gutiérrez Torres, Andrés F. Cardona, Oscar Arrieta
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2026-04-01
Serija:	BMC Cancer
Teme:	EGFR Tyrosine kinase inhibitors Toxicity Cachexia NSCLC
Online dostop:	https://doi.org/10.1186/s12885-026-15773-1
Oznake:	Označite Brez oznak, prvi označite!